Ocular Therapeutix Inc
OCUL
Market Cap$1.12B
Close$
$10.44
49.1% upside
Current Fair Value
49.1% upsideUndervalued by 49.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.12 Billion |
|---|---|
| Enterprise Value | $851.27 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.22 |
| Beta | 1.5 |
| Outstanding Shares | 169,396,989 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.21 |
|---|---|
| PEG | -0.09 |
| Price to Sales | - |
| Price to Book Ratio | 7.0 |
| Enterprise Value to Revenue | 13.89 |
| Enterprise Value to EBIT | -5.99 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ocular Therapeutix Inc
CEO: Antony Mattessich